Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Erlotinib Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,248Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Cipla
    India
    		 Ildong Pharmaceutical Co., Ltd. No. 4838-11-ND(1) Erlotinib hydrochloride 2011-06-30 Cipla Limited. India Plot No. 285, 286 and 287 Bommasandra-Jigani Link Road, Industrial Area, KIADB 4th Phase, Bengaluru-560105
    28/09/2024 Cipla
    India
    		 UNUST Co., Ltd. No. 4838-11-ND Erlotinib hydrochloride 2010-12-30 Cipla Limited India Plot No. 285, 286 and 287 Bommasandra-Jigani Link Road, Industrial Area, KIADB 4th Phase, Bengaluru-560105